Sheridan, Ageless Biotech, Inc. Sheridan, WY wani kamfani na biotech da aka ฦirฦira don kawo magungunan tushen ฦwayoyin cuta zuwa kasuwa, ya sami Cibiyar Nazarin Abinci da Magunguna ta Amurka (FDA) don maganin Osteoarthritis na Knee.
Gidauniyar Arthritis ta bayyana Osteoarthritis a matsayin "cuta ta yau da kullunโฆ ba tare da magani ba." Fiye da shekaru goma da suka wuce a cikin 2009 ABC News da aka buga, kula da lafiyar marasa lafiya na osteoarthritis a Amurka yana kashe dala biliyan 185.5 a shekara.
A cikin ษan gajeren shekaru 4 kawai, daga Gidauniyar Arthritis Foundation ta 2009 ta ba da rahoton cewa farashin OA a Amurka ya ninka kamar yadda aka buga a cikin 2013 ta rahoton CDC cewa farashin Osteoarthritis na shekara โsun kasance dala biliyan 303.5 ko 1% na 2013 Babban Kayayyakin Cikin Gida na Amurka (GDP) .โ
Shugaban Kamfanin Ageless Biotech, Inc, Vince Liguori ya yi nuni da cewa, โSamun Mataki na II OA na Gwajin Jiki na Knee ya ba mu damar fara gwaji da sauri tare da shirye-shiryen farawa a ฦarshen Maris 2022. Wannan FDA ta karษi IND ta ba da damar shekaru marasa shekaru. Biotech don kawo samfurin Osteoarthritis Stem Cell ga duka Likitoci da Marasa lafiya cikin sauri."
The Ageless Biotech IND yana amfani da ฦananan ฦwayoyin adipose da aka samo asali ba tare da enzymes ko wasu sinadarai ba ta hanyar tsarin mallakar mallakar sanannen hanyar da ake kira Stromal Vascular Fraction (SVF) wanda ke haifar da matrix na kwayoyin halitta masu rai. Ageless Biotech yana shirin tabbatar da kaddarorin sabuntawa na samfuran Ageless Biotech SVF kafin ฦarshen wannan Nazari na asibiti na FDA da aka yarda da shi yayin da yake nuna aminci da ฦarancin ฦarancin lokaci ga majiyyaci. Ageless Biotech ya yi imanin cewa miliyoyin tiyatar gwiwa na shekara za a maye gurbinsu da allurar gwiwa guda ษaya mai sauฦi. Duk da yake mun yi imanin cewa a ฦarshe za a ba da lasisin wannan fasaha ga likitocin don rarraba jama'a, muna zazzagewa cikin zafin rai "daga kan shiryayye" zaษuษษukan masu yarda da nau'in HLA don yaba irin waษannan hanyoyin kwantar da hankali a nan gaba "ba mai nisa ba".
Daraktan Tallace-tallace na BioXstem na Kasa, kuma Memba na Hukumar Kula da Biotech Ageless Jon Youngs ya bayyana hakan ta hanyar bayyanawa, โMu a BioXstem muna matukar farin cikin zama mai saka hannun jari na Ageless Biotech wanda a yanzu ba kawai magana muke yi ba. A zahiri muna iya cewa muna taka rawa sosai a cikin FDA IND da kuma wani bangare na jagoranci na ci gaban magani. โ